In the TME, cancer cells induce expression of MHC-II, CD40, CD80, and CD86 on DCs, together with the release of inflammatory cytokines like IL-12, type I IFN, IL-1β, IL-6 and tumor necrosis factor (TNF) [83]. This evidence concerns the gene IL6 and cancer.